Skip to content
Trial Eligibility
Menu

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

NCT01730131

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: - Progressive multifocal leukoencephalopathy (PML) is a severe viral infection of the brain. It is caused by JC virus. Many people have this virus in their bodies all their life, but it is usually kept in check by their immune system. If the immune system does not work right because of a disease or medication, the virus becomes active and can damage cells in the brain. Not much is known about PML or how it affects the immune system. Researchers want to study people with PML to better understand the natural history of the disease. Objectives: - To study the natural history of PML.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Progressive Multifocal Leukoencephalopathy

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
2 to 120 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Last updated on ClinicalTrials.gov
August 31, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.